{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:14:27Z","timestamp":1790306067677,"version":"4.1.0"},"reference-count":22,"publisher":"Informa UK Limited","issue":"14","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.2217\/fon.14.144","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T08:02:57Z","timestamp":1417680177000},"page":"2141-2147","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":34,"title":["Capecitabine Plus Gemcitabine in Thymic Epithelial Tumors: Final Analysis of a Phase II Trial"],"prefix":"10.1080","volume":"10","author":[{"given":"Giovannella","family":"Palmieri","sequence":"first","affiliation":[{"name":"Cancer Center for Rare Tumors of Campania & Medical Oncology Division, University Federico II of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Buonerba","sequence":"additional","affiliation":[{"name":"Cancer Center for Rare Tumors of Campania & Medical Oncology Division, University Federico II of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Ottaviano","sequence":"additional","affiliation":[{"name":"Cancer Center for Rare Tumors of Campania & Medical Oncology Division, University Federico II of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Federico","sequence":"additional","affiliation":[{"name":"Cancer Center for Rare Tumors of Campania & Medical Oncology Division, University Federico II of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Calabrese","sequence":"additional","affiliation":[{"name":"Cancer Center for Rare Tumors of Campania & Medical Oncology Division, University Federico II of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Von Arx","sequence":"additional","affiliation":[{"name":"Cancer Center for Rare Tumors of Campania & Medical Oncology Division, University Federico II of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"De Maio","sequence":"additional","affiliation":[{"name":"Cancer Center for Rare Tumors of Campania & Medical Oncology Division, University Federico II of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Marino","sequence":"additional","affiliation":[{"name":"Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Lalle","sequence":"additional","affiliation":[{"name":"Medical Oncology Division, Ospedale S Eugenio, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Montella","sequence":"additional","affiliation":[{"name":"Medical Oncology Division, Ospedale Frattamaggiore, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Merola","sequence":"additional","affiliation":[{"name":"Medical Oncology Division, Casa di Cura \u2018Villa Maria\u2019, Mirabella Eclano, Avellino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Milella","sequence":"additional","affiliation":[{"name":"Medical Oncology Division A, Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Bergaglio","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, Villa Scassi Hospital, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Lorenzo","sequence":"additional","affiliation":[{"name":"Cancer Center for Rare Tumors of Campania & Medical Oncology Division, University Federico II of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Damiano","sequence":"additional","affiliation":[{"name":"Cancer Center for Rare Tumors of Campania & Medical Oncology Division, University Federico II of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,12,4]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.11.004"},{"key":"e_1_3_3_4_1","volume-title":"Tumours of the Lung, Pleura, Thymus and Heart. Pathology & Genetics Series: World Health Organization Classification of Tumours.","author":"Travis WD","year":"2004","unstructured":"Travis WD , BrambillaE, M\u00fcller-HemerlinkHK. Tumours of the Lung, Pleura, Thymus and Heart. Pathology & Genetics Series: World Health Organization Classification of Tumours.IARC Press, Lyon, France (2004)."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2013.09.013"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00007312"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318276241c"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp483"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.3.205"},{"key":"e_1_3_3_10_1","unstructured":"National Cancer Institute . Common terminology criteria for adverse events v3.0 (2003). http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf."},{"key":"e_1_3_3_11_1","first-page":"2811","article-title":"Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2-deoxyuridine in HT-29 colon cancer cells","volume":"4","author":"Ren Q","year":"1998","unstructured":"Ren Q , KaoV, GremJL. Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2-deoxyuridine in HT-29 colon cancer cells. Clin. Cancer Res.4, 2811\u20132818 (1998).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.2446"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-011-1657-1"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0281"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.56.1.12"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.02.047"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-011-1690-0"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.4467"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v3.i7.111"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70141-9"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181d86a30"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.07.143"},{"key":"e_1_3_3_23_1","first-page":"S270","article-title":"A multicenter prospective study of carboplatin and paclitaxel for advanced thymic carcinoma: West Japan Oncology Group 4207l","volume":"8","author":"Shimizu J","year":"2013","unstructured":"Shimizu J , HiraiF, YamanakaTet al. A multicenter prospective study of carboplatin and paclitaxel for advanced thymic carcinoma: West Japan Oncology Group 4207l. J. Thorac. Oncol.8, S270 (2013).","journal-title":"J. Thorac. Oncol."},{"key":"e_1_3_3_24_1","first-page":"S268","article-title":"Clinical activity of sunitinib in patients with thymic carcinoma","volume":"8","author":"Thomas A","year":"2013","unstructured":"Thomas A , RajanA, BermanAet al. Clinical activity of sunitinib in patients with thymic carcinoma. J. Thorac. Oncol.8, S268\u2013S269 (2013).","journal-title":"J. Thorac. Oncol."}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.14.144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T02:44:17Z","timestamp":1719110657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.14.144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":22,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.2217\/fon.14.144"],"URL":"https:\/\/doi.org\/10.2217\/fon.14.144","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-12-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}